HOME > Articles >

Ann Geriatr Med Res  <  Volume 23(1); 2019 <  Articles

Ann Geriatr Med Res 2019; 23(1): 31-34  https://doi.org/10.4235/agmr.18.0045
Treatment of Cholesterol Embolism With Corticosteroids and Alprostadil
Seung Mook Jung
Department of Internal Medicine, Gimpowoori Hospital, Gimpo, Korea
Correspondence to: Seung Mook Jung, MD, https://orcid.org/0000-0001-6071-8055
Department of Internal Medicine, Gimpowoori Hospital, 11 Gamam-ro, Gimpo 10099, Korea, E-mail: jsms67@naver.com
Received: November 19, 2018; Revised: December 28, 2018; Accepted: January 27, 2019; Published online: March 31, 2019.
© The Korean Geriatrics Society. All rights reserved.

This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Cholesterol embolism is a rare but serious disease that can lead to chronic renal failure or death. Despite the recent increase in the incidence of this disease, there is no consensus on the optimal treatment modality. Supportive care is usually the mainstay of treatment. We report a case of cholesterol embolism after renal artery stenting that was successfully treated with corticosteroids and alprostadil.
Keywords: Cholesterol embolism, Corticosteroids, Alprostadil

This Article

Author ORCID Information

Social Network Service



Official Journal of

Indexed/Covered by

  • ESCI
  • DOAJ